Showing results (211-220 of 376) with videos related to

Sort By:
Pageof 38
The Journal of Clinical Endocrinology and Metabolism|November 1, 1995
Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activationB R Walker, A A Connacher, R M Lindsay, et al.
Clinical Endocrinology|August 1, 1980
The effect of cyproterone acetate on serum testosterone, LH, FSH, and prolactin in male sexual offendersW J Jeffcoate, R W Matthews, C R Edwards, et al.
Lancet (London, England)|May 5, 1990
Potentiation of hydrocortisone activity in skin by glycyrrhetinic acidS Teelucksingh, A D Mackie, D Burt, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1995
Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegalyP M Stewart, K F Kane, S E Stewart, et al.
Journal of Molecular Endocrinology|June 1, 1996
Regulation of 11 beta-hydroxysteroid dehydrogenase type 2 activity and mRNA in human choriocarcinoma cellsM M Pasquarette, P M Stewart, M L Ricketts, et al.
Clinical Endocrinology|November 1, 1995
The Birmingham pituitary database: auditing the outcome of the treatment of acromegalyD Jenkins, I O'Brien, A Johnson, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 14, 2000
Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patientsR C Baxter, F H Hawker, C To, et al.
The American Journal of Physiology|June 1, 1993
11 beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in the rat colonC B Whorwood, P C Barber, J Gregory, et al.
The Journal of Biological Chemistry|April 11, 2001
Functional expression, characterization, and purification of the catalytic domain of human 11-beta -hydroxysteroid dehydrogenase type 1E A Walker, A M Clark, M Hewison, et al.
Pageof 38